Connect with us

Technology

WELL Health Launches its AI-POWERED Co-pilot for Cardiologists powered by HEALWELL AI to Help Improve Detection of Cardiovascular Disease

Published

on

WELL has launched its new AI-powered physician co-pilot to assist cardiologists in better identifying patients at high risk of cardiovascular disease (“CVD”). WELL is exclusively partnering with HEALWELL AI, a leader in AI enabled disease diagnosis, as an extension of the WELL AI Decision Support (“WAIDS”) product offering.The co-pilot will be deployed into WELL Diagnostic Centres, Canada’s largest cardiology and medical diagnostic group, providing support and assisting cardiologists in over 40 locations across Ontario.CVD stands as the leading cause of death globally, accounting for approximately 32% of deaths worldwide in 2019(1), underscoring the critical need for early detection. HEALWELL also expects to leverage this technology to help accelerate life sciences research and development opportunities related to CVD and drive new business opportunities for its newly acquired Clinical Research Organization (“CRO”), BioPharma Services Inc.

VANCOUVER, BC and TORONTO, July 17, 2024 /PRNewswire/ – WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (“WELL” or the “Company”) a digital health company focused on tech-enabling healthcare providers, and its investee company, HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) (“HEALWELL”), a healthcare technology company focused on AI and data science for preventative care, are jointly pleased to announce the launch of WELL’s AI-powered co-pilot for cardiologists exclusively powered by HEALWELL AI, aimed at identifying patients at high risk of cardiovascular disease (“CVD”). This significant expansion of WELL’s AI capabilities builds on the success of its second-generation AI-powered physician co-pilot, WELL AI Decision Support (“WAIDS”), developed exclusively in partnership with HEALWELL. This enhancement adds to its existing rare and chronic disease detection abilities and is an extension to the WAIDS offering.

The co-pilot for cardiologists will be deployed in WELL Diagnostics Centres, Canada’s largest cardiology and medical diagnostic group with over 40 locations in Ontario. It will be available to cardiologists within the WELL Diagnostic Centres ecosystem, providing invaluable support in the early detection and management of cardiovascular disease.

Dina Sergi, CEO of WELL Diagnostic Centres, highlighted the tool’s impact, “The integration of HEALWELL’s AI-powered co-pilot for cardiologists into our WELL Diagnostic Centres represents a game-changing advancement. By offering precise risk stratification and actionable insights, this tool enhances their ability to proactively manage cardiovascular health and improve patient care.”

Dr. Alexander Dobranowski, CEO of HEALWELL, commented, “The launch of our AI-powered co-pilot for specialists marks a significant milestone in our mission to enhance healthcare through advanced technology. By expanding our AI capabilities to include cardiovascular disease detection, we are equipping cardiologists with enhanced tools and decision support necessary to identify at-risk patients earlier, ultimately improving patient outcomes and reducing healthcare costs. The integration of this tool into WELL’s Diagnostic Centres is particularly important, as it provides us access to Canada’s largest cardiology group. This vast dataset not only assists hundreds of cardiologists within the WELL Diagnostic Centres ecosystem but also allows us to continuously refine and enhance the co-pilot.”

Dr. Paul Kannampuzha, Chief Cardiology Officer of WELL Diagnostic Centres commented. “As a cardiologist, I am encouraged by how AI can help provide improved disease detection and decision support for cardiologists across the country. I believe this technology will help drive improved preventative care and ensure patients don’t fall through the cracks.”

Cardiovascular disease (CVD) is a group of disorders affecting the heart and blood vessels and is the leading cause of death globally, responsible for approximately 32% of deaths worldwide in 2019(1). In Canada, recent estimates suggest that CVD costs about $22 billion per year and is considered the second leading contributor to healthcare costs(2). Identifying patients with worsening cardiovascular conditions earlier is crucial, as cardiovascular disease is the third leading cause of death in Canada.

The global market for pharmaceutical drugs supporting cardiovascular disease was valued at approximately USD 144.1 billion in 2023. It is projected to grow at a compound annual growth rate (CAGR) of approximately 4% over the next decade, reaching an estimated USD 207.8 billion by 2033 (Precedence Research)(3). HEALWELL expects to leverage this technology to help accelerate life sciences research and development opportunities related to CVD and drive new business opportunities for its newly acquired Clinical Research Organization (CRO), BioPharma Services Inc.

Footnotes:

https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-%28cvds%29https://link.springer.com/article/10.1007/s41669-021-00257-8https://www.precedenceresearch.com/cardiovascular-drugs-market

About WELL Health Technologies Corp.

WELL’s mission is to tech-enable healthcare providers. We do this by developing the best technologies, services, and support available, which ensures healthcare providers are empowered to positively impact patient outcomes. WELL’s comprehensive healthcare and digital platform includes extensive front and back-office management software applications that help physicians run and secure their practices. WELL’s solutions enable more than 34,000 healthcare providers between the US and Canada and power the largest owned and operated healthcare ecosystem in Canada with more than 175 clinics supporting primary care, specialized care, and diagnostic services. In the United States WELL’s solutions are focused on specialized markets such as the gastrointestinal market, women’s health, primary care, and mental health. WELL is publicly traded on the Toronto Stock Exchange under the symbol “WELL” and on the OTC Exchange under the symbol “WHTCF”. To learn more about WELL, please visit: www.well.company.

About HEALWELL AI

HEALWELL is a healthcare technology company focused on AI and data science for preventative care. Its mission is to improve healthcare and save lives through early identification and detection of disease. Using its own proprietary AI technology and competencies which includes data science, electronic health records and clinical research offerings, the Company is developing and commercializing advanced clinical decision support systems that can help healthcare providers detect rare and chronic diseases, improve efficiency of their practice and ultimately help improve patient health outcomes. HEALWELL is publicly traded on the Toronto Stock Exchange under the symbol “AIDX” and on the OTC Exchange under the symbol “HWAIF”. To learn more about HEALWELL, please visit https://healwell.ai/.

Forward-Looking Statements

Certain statements in this press release, constitute “forward-looking information” and “forward looking statements” (collectively, “forward looking statements”) within the meaning of applicable Canadian securities laws and are based on assumptions, expectations, estimates and projections as of the date of this press release. Forward-looking statements in this press release include statements with respect to, among other things, the deployment of WAIDS at WELL Health Diagnostic Centres, the use of the WAIDS to improve patient care, and the use of AI technology by HEALWELL to drive research and development opportunities related to CVD. Forward-looking statements are often, but not always, identified by words or phrases such as “opportunity”, “potential”, “improve”, “expect”, “intend”, “create” or variations of such words and phrases or statements that certain future conditions, actions, events or results “will”, “may”, “could”, “would”, “should”, “might” or “can” be taken, occur or be achieved, or the negative of any of these terms . Forward-looking statements are necessarily based upon management’s perceptions of historical trends, current conditions and expected future developments, as well as a number of specific factors and assumptions that, while considered reasonable by HEALWELL as of the date of such statements, are outside of HEALWELL’s control and are inherently subject to significant business, economic and competitive uncertainties and contingencies which could result in the forward-looking statements ultimately being entirely or partially incorrect or untrue. Forward looking statements contained in this press release are based on various assumptions, including, but not limited to: the ability of HEALWELL to utilize AI technologies to detect CVD indicators; the ability to collaborate with the pharmaceutical industry for research and development opportunities, HEALWELL’s continued compliance with third party intellectual property rights; HEALWELL’s continued compliance with privacy laws; and that the risk factors noted below, collectively, do not have a material impact on HEALWELL’s business, operations, revenues and/or results. By their nature, forward-looking statements are subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections, or conclusions will not prove to be accurate, that assumptions may not be correct, and that objectives, strategic goals and priorities will not be achieved.

Known and unknown risk factors, many of which are beyond the control of HEALWELL, could cause the actual results of HEALWELL to differ materially from the results, performance, achievements, or developments expressed or implied by such forward-looking statements. Such risk factors include but are not limited to those factors which are discussed under the section entitled “Risk Factors” in HEALWELL’s most recent annual information form dated April 1, 2024, which is available under HEALWELL’s SEDAR+ profile at www.sedarplus.com. The risk factors are not intended to represent a complete list of the factors that could affect HEALWELL and the reader is cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking statements. There can be no assurance that forward looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Forward-looking statements are provided for the purpose of providing information about management’s expectations and plans relating to the future. HEALWELL disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, or to explain any material difference between subsequent actual events and such forward-looking statements, except to the extent required by applicable law. All of the forward-looking statements contained in this press release are qualified by these cautionary statements.

View original content to download multimedia:https://www.prnewswire.com/news-releases/well-health-launches-its-ai-powered-co-pilot-for-cardiologists-powered-by-healwell-ai-to-help-improve-detection-of-cardiovascular-disease-302198990.html

SOURCE WELL Health Technologies Corp.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

TVU Networks Revolutionizes Live Broadcasting with Cloud and AI-Powered Solutions at Broadcast India 2024

Published

on

By

CUPERTINO, Calif., Sept. 25, 2024 /PRNewswire/ — TVU Networks, a global leader in IP and cloud-based live video solutions, will showcase its latest innovations at Broadcast India 2024, October 17-19, booth J1-A. These groundbreaking technologies are set to revolutionize the broadcasting industry.

Empowering Broadcasters with Agile Solutions

Paul Shen, CEO of TVU Networks, underscores the company’s collaborative ethos: “We’re not just providing tools; we’re partnering with broadcasters to transform their live production capabilities. Our goal is to empower our partners with the agility needed to meet evolving audience demands, shaping the future of live broadcasting with tangible results today.”

Microservices: The Heart of TVU’s Innovation

At the core of TVU’s engineering philosophy are microservices—modular building blocks enabling powerful new capabilities. By leveraging hundreds of microservices within TVU transmitters and SaaS applications, broadcasters can swiftly create dynamic workflows that seamlessly integrate with on-premise infrastructures. Since 2019, TVU has been integrating AI into these microservices, further streamlining tasks and expanding coverage capabilities.

Unleashing Flexibility with TVU MediaHub™ and Hybrid Workflows

The six-time award-winning MediaHub allows broadcasters to ingest unlimited sources into the TVU ecosystem, enabling seamless switching within SaaS applications like TVU Producer. TVU’s Agent, deployable on existing on-premise hardware, offers unparalleled flexibility in managing processing and resource use. This innovative solution, proven in large-scale productions such as the Sertoes Rally in Brazil, exemplifies TVU’s commitment to maximizing media workflow efficiency.

Enhancing Operations and Visibility

A notable innovation in TVU’s suite of solutions is the Network Operations Center (NOC), providing unprecedented visibility into cloud, on-premise, and hybrid media supply chains. This powerful tool offers broadcasters comprehensive control and insight into their operations, allowing for efficient management of complex broadcasting workflows across various environments.

Pioneering the Future of Broadcasting

By harnessing cutting-edge technologies such as cloud computing, AI, and 5G, TVU Networks continues to pioneer adaptive solutions for the ever-evolving media landscape. These technologies work in concert to provide broadcasters with unparalleled capabilities in content creation, management, and distribution.

Visitors to Broadcast India 2024 are invited to experience TVU Networks’ end-to-end ecosystem of cloud-based solutions at booth J1-A, witnessing firsthand how these innovations are shaping the future of the media supply chain.

Learn More: https://info.tvunetworks.com/bi-2024

Photo – https://mma.prnewswire.com/media/2513881/20240919172458.jpg 

View original content:https://www.prnewswire.com/in/news-releases/tvu-networks-revolutionizes-live-broadcasting-with-cloud-and-ai-powered-solutions-at-broadcast-india-2024-302256943.html

Continue Reading

Technology

Hyundai Motor Group Unveils End-to-End Hydrogen Solutions and Hydrogen Roadmap at H2 MEET 2024

Published

on

By

Hyundai Motor Group unveils comprehensive hydrogen technology solutions and a roadmap at H2 MEET 2024, Korea’s largest hydrogen industry eventThe Group is showcasing its hydrogen business and technology under the HTWO, emphasizing its unique capabilities and strong collaboration among affiliatesHydrogen value chain business solutions are exhibited as part of four scenarios: Energy Security, Port & Airport Decarbonization, Industrial Applications & Businesses and Hydrogen Society

SEOUL, South Korea, Sept. 24, 2024 /CNW/ — Hyundai Motor Group (the Group) unveiled its end-to-end hydrogen solutions and roadmap at H2 MEET 2024[1], Korea’s largest hydrogen industry exhibition event, running from September 25 to 27 at the Korea International Exhibition Center (KINTEX) near Seoul.

Under the theme ‘Be a First Mover in Hydrogen,’ the Group introduced its hydrogen business and technology spanning the entire hydrogen value chain under the HTWO brand. This builds upon its hydrogen vision presentation made at this year’s Consumer Electronics Show (CES).

H2 MEET 2024 marks the first event in which all the Group’s affiliates are participating together under the HTWO. Participating affiliates include Hyundai Motor Company, Hyundai Rotem, Hyundai Steel, Hyundai Engineering, Hyundai E&C and Hyundai Glovis.

At its massive H2 MEET booth, the Group is showing four hydrogen value chain business solutions in four scenario-based exhibitions with staff available for explanation at each exhibition corner and digital docents available via smartphones.

The first scenario exhibition, ‘Energy Security,’ introduces the Group’s innovative resource-cycle hydrogen production technologies including W2H (Waste-to-Hydrogen) and P2H (Plastic-to-Hydrogen). W2H utilizes organic waste such as food and sewage sludge to produce hydrogen, while P2H utilizes non-recyclable plastic. The exhibition also showcases Korea‘s very first W2H facility in Chungju that converts food waste into hydrogen and supplies hydrogen to nearby refueling stations.

Visitors will also be able to check on Hyundai Motor’s field-proven cell system and its reverse electrolysis technology – PEM electrolysis, which is ideal for producing high-purity hydrogen. The exhibit also features Korea’s very first PEM electrolysis production facility in Buan, operated by Hyundai E&C, alongside other business cases that run on the hydrogen produced. 

The second scenario exhibition, ‘Port & Airport Decarbonization’ introduces hydrogen solutions that can be applied to high-carbon-emitting industrial complexes, including ports and airports. Hyundai Motor successfully deployed a pioneering fleet of 30 Class 8 XCIENT Fuel Cell hydrogen-powered trucks for the NorCAL ZERO Project since last year with an aim to reduce carbon emissions at the port of Oakland in California, U.S.

More information about Hyundai Motor Group can be found at: http://www.hyundaimotorgroup.com or Newsroom: Media Hub by Hyundai, Kia Global Media Center (kianewscenter.com), Genesis Newsroom

[1] H2 MEET stands for ‘Hydrogen Mobility Energy Environment Technology’

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/hyundai-motor-group-unveils-end-to-end-hydrogen-solutions-and-hydrogen-roadmap-at-h2-meet-2024-302257920.html

SOURCE Hyundai Motor Group

Continue Reading

Technology

Inside information: Valmet to supply a complete pulp mill with full-scope automation and flow control solutions to Arauco in Brazil

Published

on

By

Valmet Oyj’s stock exchange release (inside information) on September 25, 2024 at 01:45 a.m. EEST

ESPOO, Finland, Sept. 25, 2024 /PRNewswire/ — The Board of Directors of Arauco have today approved an investment of a complete pulp mill and selected Valmet as the supplier for the project. Valmet’s scope will be the delivery of complete pulp mill including also full-scope automation and flow control solutions to Arauco. The new pulp mill will be the world’s largest single-phase pulp mill project with 3.5 million tonne per year pulp production capacity. The new mill is estimated to start-up in the second half of 2027.  The pulp mill will be built in Inocência, in the state of Mato Grosso do Sul, Brazil.

The contract is estimated to be finalized by the end of 2024.

The value of the order for Valmet is over EUR 1 billion, and it is expected to be included in Valmet’s orders received for the fourth quarter 2024. The anticipated delivery will have an important employment impact on Valmet and its subcontractors especially in Brazil, Finland, Sweden, Denmark, India and China.

“This is an important and decisive stage of our Sucuriú Project, which will feature high expertise and state-of-the-art technology. As the world’s largest single-phase pulp production project, our choice to partner with Valmet reflects Arauco’s commitment to partnering with those who share our vision for innovation and sustainable practices,” says Cristian Infante, Global CEO of Arauco.

“This investment is a significant milestone for the industry, and we are proud to be selected as the partner for Arauco in this major project. Arauco’s new pulp mill will be the largest single-phase pulp mill project in the world and will be a showcase for Valmet’s sustainable technologies. In addition, the mill will generate a significant amount of excess bioelectricity, contributing positively to the sustainable energy supply of the area,” says Thomas Hinnerskov, President and CEO of Valmet.

“With a complete mill delivery, Valmet can offer the full benefits of our innovative and comprehensive offering consisting of process technology, automation systems, flow control solutions and services. Even though the mill will be the largest ever delivered, Valmet’s delivery scope will include proven technologies creating a good foundation for this mega mill investment. The mill will feature leading process technologies, including the latest developments in our continuous cooking technology especially tailored for large hardwood mills and the most advanced automation systems and flow control solutions. Complete automation solution includes the latest Valmet DNAe automation system together with mill-wide optimization solution. The solutions are designed to deliver excellent energy efficiency, optimized end-product quality, and high environmental performance,” says Sami Riekkola, Business Line President, Pulp and Energy, Valmet.

“The development of the pulp industry in Brazil has been substantial in the past years. To meet the demands of this market and serve the customers even better in the region, Valmet has systematically strengthened its presence and competences locally. Our knowledge about the local conditions, experience in executing projects and commitment to provide long-term services for the new plant ensuring high operational efficiency and sustainability were recognized by Arauco as very important factors in their decision to partner with Valmet,” says Celso Tacla, Area President, South America, Valmet.

Details about Valmet’s technology delivery to Arauco Sucuriú pulp mill project

Valmet will deliver the full production process from wood handling to ready pulp bales to produce hardwood pulp, as well as automation system and related flow control solutions for the whole mill including features form Valmet’s Industrial Internet offering. Valmet’s delivery scope includes the engineering, procurement, and construction, including civil construction and commissioning works at the site.

Valmet’s process technology delivery will include wood handling, cooking and fiber line, pulp drying and baling, non-condensable gases (NCG) handling solution, evaporation, recovery boiler, biomass boiler, recausticizing, lime kiln, biomass dryer and gasifier.

The automation delivery will include Valmet’s latest distributed control system Valmet DNAe, advanced process controls (APC), analyzers and online measurements as well as mill-wide optimization covering all process islands. The Industrial Internet solutions scope includes simulators and connectivity to Valmet Performance Center.

The delivery will additionally include flow control solutions featuring valves and valve automation. 

Information about the customer Arauco

Arauco is a global forest industry company, originally from Chile, with a presence on five continents. Founded in 1979, it has operations in more than 75 countries and 55 mills in Brazil, Chile, Argentina, Uruguay, Mexico, the United States, Canada, Germany, Spain, Portugal, and South Africa. It operates globally with over 18,000 employees guided by solid values and common vision of contributing to improving the lives of people and the planet, developing renewable forest products for the challenges of a sustainable world.  

Further information, please contact:
Sami Riekkola, Business Line President, Pulp and Energy, Valmet, tel. +358 40 542 7437
Celso Tacla, Area President, South America, Valmet, tel. +55 41 3341 458
Pekka Rouhiainen, VP, Investor Relations, Valmet, tel. +358 10 672 0020
Anu Salonsaari-Posti, SVP, Communications, marketing, sustainability and corporate relations, Valmet, tel. +358 50 453 4262

VALMET

Katri Hokkanen
CFO 

Pekka Rouhiainen
VP, Investor Relations

DISTRIBUTION:
Nasdaq Helsinki
Major media
www.valmet.com

Valmet has a global customer base across various process industries. We are a leading global developer and supplier of process technologies, automation and services for the pulp, paper and energy industries. With our automation systems and flow control solutions we serve an even wider base of process industries. Our more than 19,000 professionals around the world work close to our customers and are committed to moving our customers’ performance forward – every day.

The company has over 220 years of industrial history and a strong track record in continuous improvement and renewal. Valmet’s net sales in 2023 were approximately EUR 5.5 billion.

Valmet’s shares are listed on the Nasdaq Helsinki and the head office is in Espoo, Finland. 

Follow us on valmet.com | X | X (IR) | LinkedIn | Facebook | YouTube | Instagram |

Processing of personal data

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/valmet-oyj/r/inside-information–valmet-to-supply-a-complete-pulp-mill-with-full-scope-automation-and-flow-contro,c4042192

 

View original content:https://www.prnewswire.co.uk/news-releases/inside-information-valmet-to-supply-a-complete-pulp-mill-with-full-scope-automation-and-flow-control-solutions-to-arauco-in-brazil-302257923.html

Continue Reading

Trending